For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Dyne Therapeutics, Inc.

USPTO Granted Patents = 52

Trademarks = 6

Forward Citations = 1,132

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Romesh R Subramanian (52 out of 68 patents)

Mohammed T Qatanani (52 out of 52 patents)

Timothy Weeden (52 out of 52 patents)

4. Cody A Desjardins (32 out of 32 patents)

5. Brendan Quinn (23 out of 23 patents)

6. John Najim (23 out of 23 patents)

7. Scott Hilderbrand (3 out of 4 patents)

8. Stefano Zanotti (2 out of 2 patents)

9. Kim Tang (2 out of 2 patents)

10. Sean Spring (1 out of 1 patent)

11. Peiyi Shen (1 out of 1 patent)

Core Competencies:

Muscle Targeting Complexes

Anti-Transferrin Receptor Antibody

Oligonucleotide Delivery

Dystrophinopathies

Myotonic Dystrophy

Exon Skipping

Duchenne Muscular Dystrophy

Facioscapulohumeral Muscular Dystrophy

Therapeutic Formulations

RNA Targeting

Complexes for Treatment

Muscle Weakness

52 patents: Sort by Forward Citations

1. 12460011 - Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering an oligonucleotide to a subject (2025-11-04),

2. 12440575 - Muscle targeting complexes and uses thereof for treating dystrophinopathies (2025-10-14),

3. 12440574 - Muscle targeting complexes and formulations for treating myotonic dystrophy (2025-10-14),

4. 12428487 - Complexes comprising an anti-transferrin receptor antibody linked to an oligonicleotide and method of delivering oligonucleotide to a subject (2025-09-30),

5. 12403203 - Muscle targeting complexes and uses thereof for treating dystrophinopathies (2025-09-02),

6. 12397062 - Muscle targeting complexes and uses thereof for treating dystrophinopathies (2025-08-26),

7. 12370264 - Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject (2025-07-29),

8. 12357703 - Muscle-targeting complexes comprising an anti-transferin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping (2025-07-15),

9. 12329825 - Muscle targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping of exon 44 of dystrophin in a subject (2025-06-17),

10. 12329824 - Muscle targeting complexes and uses thereof for treating dystrophinopathies (2025-06-17),

11. 12325753 - Method of using an anti-transferrin receptor antibody to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy (2025-06-10),

12. 12319743 - Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject (2025-06-03),

13. 12280122 - Muscle targeting complexes and uses thereof for treating myotonic dystrophy (2025-04-21),

14. 12263225 - Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of use thereof to target dystrophin and to treat Duchenne muscular dystrophy (2025-04-01),

15. 12239717 - Muscle targeting complexes and uses thereof for treating dystrophinopathies (2025-03-04),

Dyne Therapeutics, Inc. is a biotechnology company focused on developing life-changing therapies for patients with serious muscle diseases. Their innovative platform technology enables the delivery of nucleic acids to muscle tissues, aiming to provide long-lasting therapeutic benefits. By harnessing the power of synthetic polymers, Dyne Therapeutics aims to revolutionize the treatment landscape for muscular disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

52 Patents

#23 in Waltham, MA

#374 in Massachusetts

#6,542 in US

#13,162 in the World

Waltham, MA, United States of America

Dyne Therapeutics, Inc.

Forward Citations = 1,132

11 inventors:

Romesh R Subramanian (52 out of 68 patents)

Mohammed T Qatanani (52 out of 52 patents)

Timothy Weeden (52 out of 52 patents)

4. Cody A Desjardins (32 out of 32 patents)

5. Brendan Quinn (23 out of 23 patents)

Please report any incorrect information to support@idiyas.com

Loading…